Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies across ...
Alongside the complete kit, TheWell Bioscience has released the RocketCell (TM) iPSC Xeno-Free Growth Medium. Available as a standalone product, this xeno-free medium is designed for researchers who ...
As of Thursday, January 08, Century Therapeutics, Inc.’s IPSC share price has surged by 30.65%, which has investors ...
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
XCells Biotechnologies, a provider of human cell-based solutions and custom iPSC services, has appointed Steve Smith as CEO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback